Price $2.52 |
Market Cap
466M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.19
|
P/S
2.08
|
Dividend %
-
|
|
P/CF
8.4
|
P/FCF
-
|
Op. Cash Flow
-220.9K
|
FCF
-
|
|
Op. Margin
-135.10%
|
Net Margin
-142.00%
|
ROE
-154.70%
|
ROI
-109.40%
|
|
ROA
-48.10%
|
EPS Growth
35.70%
|
Current Ratio
2.0
|
Debt/Equity
38.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $56.32 | - | 3.50% | 122.99B | Strong Buy |
| Endo International PLC (ENDP) | $4.99 | - | - | 1.23B | Strong Buy |
| Assertio Holdings Inc (ASRT) | $1.35 | - | - | 62.9M | Strong Buy |
| Viatris Inc (VTRS) | $12.20 | - | 3.60% | 14.75B | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.20 | - | - | 34.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
